ClinicalTrials.govcontrolled
Open Label Study to Evaluate Safety and Efficacy of 2 Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT01565668. IPD Sharing: YES. Countries: 4. Publications: 0.
ShareScore
32/100
Overall dataset sharing score
Score breakdown
These five areas show where the dataset supports — or may limit — practical reuse.
- Stewardship
- 16
- Harmonization
- 8
- Access
- 4
- Reuse readiness
- 0
- Engagement
- 4